Cargando…

Tear cytokine response to multipurpose solutions for contact lenses

PURPOSE: An increased risk of corneal infiltrative events has been noted with the use of certain contact lenses and multipurpose solutions (MPS). This study was designed to evaluate tear cytokine assay as a sensitive, objective, and quantitative measure of the ocular surface response to contact lens...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalsow, Carolyn M, Reindel, William T, Merchea, Mohinder M, Bateman, Kirk M, Barr, Joseph T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700914/
https://www.ncbi.nlm.nih.gov/pubmed/23847409
http://dx.doi.org/10.2147/OPTH.S44642
_version_ 1782275559500283904
author Kalsow, Carolyn M
Reindel, William T
Merchea, Mohinder M
Bateman, Kirk M
Barr, Joseph T
author_facet Kalsow, Carolyn M
Reindel, William T
Merchea, Mohinder M
Bateman, Kirk M
Barr, Joseph T
author_sort Kalsow, Carolyn M
collection PubMed
description PURPOSE: An increased risk of corneal infiltrative events has been noted with the use of certain contact lenses and multipurpose solutions (MPS). This study was designed to evaluate tear cytokine assay as a sensitive, objective, and quantitative measure of the ocular surface response to contact lens/MPS and to consider the assay’s clinical relevance in the context of other measures of ocular surface response. METHODS: Two MPS, ReNu® Fresh™ (RNF) and Opti-Free® RepleniSH (OFR), were used with daily wear silicone hydrogel contact lenses in a randomized, prospective crossover study involving 26 subjects. Clinical data collection (conjunctival hyperemia, ocular surface sensitivity, solution induced corneal staining (SICS) test score, and subjective responses) and tear cytokine assays were conducted masked. Responses were tracked as change from baseline throughout the experimental schedule. RESULTS: Similar response patterns for several inflammatory cytokines were seen throughout both phases: subjects who received OFR in Phase I had mean tear concentrations that were generally higher than those of the RNF Phase I group. OFR Phase I subjects had significant (P < 0.01) increases over baseline at day 1 and/or following washout for 13 cytokines (cc chemokine ligands [CCL] 3, CCL5, CCL11, granulocyte-macrophage colony-stimulating factor [GM-CSF], interferon [INF]-γ, interleukin [IL]-2, IL-4, IL-5, IL-6, IL-13, IL-15, IL-17, tumor necrosis factor [TNF]-α). These changes were not observed in RNF Phase I subjects, even though SICS test scores increased. Phase I OFR subjects also had increased dryness, while RNF Phase I subjects had decreased bulbar hyperemia. No changes were detected with respect to limbal hyperemia or surface sensitivity thresholds. CONCLUSION: The tear cytokine assay can detect and differentiate contact lens/MPS induced increases in inflammatory cytokines. Changes in cytokine levels were consistent with measurement of hyperemia and dryness but not with SICS scores, thereby suggesting a proinflammatory response to OFR compared to RNF that is not related to SICS test score. Tear cytokine profiles may be useful for reconciling clinical relevance of test results and in revealing signaling involved in the development of corneal infiltrative events.
format Online
Article
Text
id pubmed-3700914
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-37009142013-07-11 Tear cytokine response to multipurpose solutions for contact lenses Kalsow, Carolyn M Reindel, William T Merchea, Mohinder M Bateman, Kirk M Barr, Joseph T Clin Ophthalmol Original Research PURPOSE: An increased risk of corneal infiltrative events has been noted with the use of certain contact lenses and multipurpose solutions (MPS). This study was designed to evaluate tear cytokine assay as a sensitive, objective, and quantitative measure of the ocular surface response to contact lens/MPS and to consider the assay’s clinical relevance in the context of other measures of ocular surface response. METHODS: Two MPS, ReNu® Fresh™ (RNF) and Opti-Free® RepleniSH (OFR), were used with daily wear silicone hydrogel contact lenses in a randomized, prospective crossover study involving 26 subjects. Clinical data collection (conjunctival hyperemia, ocular surface sensitivity, solution induced corneal staining (SICS) test score, and subjective responses) and tear cytokine assays were conducted masked. Responses were tracked as change from baseline throughout the experimental schedule. RESULTS: Similar response patterns for several inflammatory cytokines were seen throughout both phases: subjects who received OFR in Phase I had mean tear concentrations that were generally higher than those of the RNF Phase I group. OFR Phase I subjects had significant (P < 0.01) increases over baseline at day 1 and/or following washout for 13 cytokines (cc chemokine ligands [CCL] 3, CCL5, CCL11, granulocyte-macrophage colony-stimulating factor [GM-CSF], interferon [INF]-γ, interleukin [IL]-2, IL-4, IL-5, IL-6, IL-13, IL-15, IL-17, tumor necrosis factor [TNF]-α). These changes were not observed in RNF Phase I subjects, even though SICS test scores increased. Phase I OFR subjects also had increased dryness, while RNF Phase I subjects had decreased bulbar hyperemia. No changes were detected with respect to limbal hyperemia or surface sensitivity thresholds. CONCLUSION: The tear cytokine assay can detect and differentiate contact lens/MPS induced increases in inflammatory cytokines. Changes in cytokine levels were consistent with measurement of hyperemia and dryness but not with SICS scores, thereby suggesting a proinflammatory response to OFR compared to RNF that is not related to SICS test score. Tear cytokine profiles may be useful for reconciling clinical relevance of test results and in revealing signaling involved in the development of corneal infiltrative events. Dove Medical Press 2013 2013-06-28 /pmc/articles/PMC3700914/ /pubmed/23847409 http://dx.doi.org/10.2147/OPTH.S44642 Text en © 2013 Kalsow et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Kalsow, Carolyn M
Reindel, William T
Merchea, Mohinder M
Bateman, Kirk M
Barr, Joseph T
Tear cytokine response to multipurpose solutions for contact lenses
title Tear cytokine response to multipurpose solutions for contact lenses
title_full Tear cytokine response to multipurpose solutions for contact lenses
title_fullStr Tear cytokine response to multipurpose solutions for contact lenses
title_full_unstemmed Tear cytokine response to multipurpose solutions for contact lenses
title_short Tear cytokine response to multipurpose solutions for contact lenses
title_sort tear cytokine response to multipurpose solutions for contact lenses
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700914/
https://www.ncbi.nlm.nih.gov/pubmed/23847409
http://dx.doi.org/10.2147/OPTH.S44642
work_keys_str_mv AT kalsowcarolynm tearcytokineresponsetomultipurposesolutionsforcontactlenses
AT reindelwilliamt tearcytokineresponsetomultipurposesolutionsforcontactlenses
AT mercheamohinderm tearcytokineresponsetomultipurposesolutionsforcontactlenses
AT batemankirkm tearcytokineresponsetomultipurposesolutionsforcontactlenses
AT barrjosepht tearcytokineresponsetomultipurposesolutionsforcontactlenses